70 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
and the related FDA Draft Guidance, in the development of Next Generation Chemotherapy (“NGC”) oncology drug products. Our mission is to provide better … mission. We continue to be focused on drug products that improve the survival and/or quality of life for patients by improving the safety and/or efficacy
8-K
EX-99.1
33pm47u 1hh
31 Mar 23
Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results
8:30am
8-K
EX-99.1
xt9dkat0sb32og3
14 Dec 22
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
11:22am
8-K
EX-99.2
89fsutoi eebrx2em2d
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
l6rt6hqe3lpjcdb
8 Nov 22
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
apaopf8o
4 Nov 22
Other Events
11:24am
8-K
EX-99.1
z6x5q47atmybt5sd
12 Aug 22
Processa Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
10:35am
8-K
EX-99.1
457k2noctldt8s
4 Aug 22
Regulation FD Disclosure
9:30am
8-K
EX-99.1
2ap4snueii816dng
12 May 22
Processa Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update
4:21pm